Bioenergy Rides Pharma Science Down Rx, Supplement Roads
This article was originally published in The Pink Sheet Daily
Executive Summary
Bioenergy Life Science, a subsidiary of biotech firm Bioenergy, is designing phase III clinical studies and plans to submit an NDA for Bioenergy Ribose in parenteral form for acute use in pre- and post-surgical patients and as a biologic preservative.